Profile
Justin McCue is currently Chief Technology Officer at TScan Therapeutics, Inc. since 2023.
Dr. McCue is also Chief Technology Officer & Senior Vice President at Akebia Therapeutics, Inc. starting in 2026.
Formerly, Dr. McCue was Chief Technology Officer at Avectas Ltd. from 2022 to 2023.
Dr. McCue was Vice President-Technical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2022.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.
Justin McCue active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/12/2023 |
| AKEBIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2026 |
Former positions of Justin McCue
| Companies | Position | End |
|---|---|---|
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Provides cellular biotechnology services | Chief Tech/Sci/R&D Officer | 01/12/2023 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Chief Tech/Sci/R&D Officer | 01/07/2022 |
Training of Justin McCue
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Provides cellular biotechnology services | Commercial Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
- Stock Market
- Insiders
- Justin McCue
















